We describe 2 cases of bilateral Meniere disease with features resembling autoimmuneinnereardisease in patients who were found to be carriers of human leukocyte antigen (HLA) B27. For immunohistochemical analysis, mouse inner earsections were usedas the tissue substrate for reaction with serum. Both patients demonstrated an increased immunofluorescencereaction compared with a normal control. We suggest that an antibody-mediated mechanism may be responsiblefor HLA-B27-associated Meniere disease.
Introduction
The etiology of Meniere disease is thought to be multifactorial, involving both genetic and environmental factors. 1 In several studies oftemporal bones, researchers have attemp ted to correlate pathologic findings with a known clinical history in Meniere disease, suggesting congenital, infectious, inflammatory, traumatic,allergic, and autoimmune causes.'
The idea of an autoimmune etiology of inner ear disease was first introduced more than 30 years ago,' and it still remains an active area of research today. Autoimmune inner ear disease is defined by many authors as a bilateral progressive hearing loss that responds to a short course ofhigh-dose oral steroid treatment. 3 Studies have demonstrated that 20 to 50% of patients classified as having autoimmune inner ear disease have vestibular symptoms that are corr elated with Meniere disease.l"
It is assumed that autoimmunity occurs via one of 'three basic pathways to cause tissue damage in Meniere disease, which mayor may not be organ-specific: (1) autoantibodies directed against antigens found upon or within tissue cells,6-1O (2) circulation and deposition of antigen-antibody complexes with activation of the complement system and resultant inflammatory tissue destruction.s '?!' or (3) an inflammatory reaction mediated by sensitized T lymphocytes.P-'! The association between the human leukocyte antigen (HLA) complex and Meniere disease has been explored, but results have varied among different populations worldwide. 12 -16 Specifically, no association between HLA-B27 and Meniere disease or autoimmune inner ear disease has been described.
We report 2 cases of HLA-B27-associated Meniere disease, and we describe their clinical and immunocytologic features as determined by the patients' serum reactions with mouse inner ears.
Case reports
Patient 1. A 64-year-old man presented with episodic vertigo, aural pressure, tinnitus, vertebral arthritis, and a progressive bilateral sensorineural hearing loss, His medical history was significant for chronic low back pain. He also related a strong association ofepisodes with salt and caffeine intake. The patient had earlier been treated for 2 episodes ofsudden sensorineural hearing loss-one in 1984 and one in 1991. Both episodes resolved after a course of steroid therapy. Starting in 1993, the patient began experiencing regular episodes (every 6 mo) of bilateral sudden sensorineural hearing loss and vertigo lasting 3 to 4 hours. These episodes were very responsive to intramuscular steroid treatment.
In March 2003, the patient was referred to our clinic. Laboratory tests revealed that his erythrocyte sedimentation rate (ESR), antinuclear antibody (ANA) level, rheumatoid factor (RF) value, and fluorescent treponemal antibody absorption (FTA-ABS) titers were within normal limits. Findings on magnetic resonance imaging (MRI) of the internal auditory canals were normal. Pure-tone audiometry was obtained during an episode of vertigo and again after treatment with 40 mg of methylprednisolone given intramuscularly (figure 1). In light ofthe discoveryofHLA-B27in a family member, the patient underwent HLA testing, which revealed that he, too, was a carrier of HLA-B27.
Patient 2. A 71-year-old man presented with a 10month history of fluctuating bilateral hearing loss and occasional vertigo, aural pressure, and tinnitus. He had had a previous diagnosis of cervical arthritis. His ESR, ANA,RF, and FTA-ABS values werewithin normal limits. Findings on a previously obtained MRI of the internal auditory canals were normal. Audiometry revealed a sensorineural hearing lossdown to 70dB on the right and 60 dB on the left across all frequencies. On questioning, the patient also reported recurring pink eye about every 4 months. Cogan syndrome was initially suspected in view of the characteristic interstitial keratitis, fluctuating sensorineural hearing loss, and episodic vertigo.
The patient was treated with 60 mg oforal prednisone every day for 1week with a taper, but there was no change in symptoms. When a review of the patient's ophthalmologic examination revealed that he suffered from recurrent iritis and not interstitial keratitis or uveitis, the diagnosis of Cogan syndrome was questioned. Additionally, weexplored his complaint of cervical arthritis and found ankylosing spondylitis. At this point, the idea of an association with HLA-B27 was introduced, and subsequent blood tests revealed that the patient was indeed a carrier of the HLA-B27 allele. With this working diagnosis ofan HLA-B27genotype, the patient continued treatment with intratympanic dexamethasone. The following week, he reported no change in symptoms, and audiometry revealed a worsening of his hearing loss to 80 dB at 250 to 500 Hz on the right and to 90 dB at 250 to 500 Hz on the left.
Intratympanic injections were performed again bilaterally in the office, and the hearing in the right ear improved from its lowest threshold of75 dB at both 250 and 500 Hz to 60 dB (figure 2). Similar improvement was seen on the left side, with increases from 95 to 75 dB at 250 Hz and from 85 to 70 dB at 500 Hz 125 250 500 1,000 2,000 4,000 8,000 125 250 500 1,000 2,000 4,000 8,000
Hz Hz ( figure 6 ). There was no difference noted in the pattern or amount of immunofluorescence between the paraformaldehyde preparation and the acetone preparation. These results suggest that a humoral immune responsespecificallyan antigen-an tibody reaction-may underlie the development of Meniere disease symptomatology in carriers ofHLA-B27.
Discussion
We have described the cases of 2 patients with signs and symptoms of autoimmune Meniere disease who were found to be HLA-B27 carriers. Reaction of the serum of these patients with mouse cochlear sections showed a greater antigen-antibody reaction compared with control specimens. However, no common pattern of immune reaction was seen in the 2 patients. The results of our investigation indicate a possible role of HLA-B27 in the development of autoimmune , bilateral Meniere disease. The relationship between autoimmune Meniere disease and HLA-B27 carriage is worthy of further study. Our patients' bilateral progressive asymmetrical hearing loss supports an autoimmune etiology. Both of our patients had symptoms ofepisodic vertigo, aural pressure, tinnitus, vertebral arthritis, and progressive sensorineural hearing loss-a hearing loss primarily in the lower frequencies that over time involved the higher frequencies. Patient 2 demonstrated a more rapid progression over a short period of time, whereas patient 1 had a more protracted course. Patient 1 also related a strong association of episodes with salt and caffeine intake. It is possible that the cochlear and vestibular 126 • www.entjournal.com symptoms in both patients were related to their HLA-B27-positive serology.
Since 1979, researchers have been studying the potential autoimmune etiology of Meniere disease.' More specifically, its, association with particular HLAs has been explored, but results among different populations worldwide have varied. P:" Many authors have reported a high prevalence ofMeniere-type symptoms in carriers ofthe HLA-Cw"07,12-Cw"0602,13-DRBI " 1602,14_A2,IS and -B44 15 alleles. Yeta group from Spain reported no association between Meniere disease and HLA-A, -B, -C, or -DR alleles." To date, no link has been shown between HLA-B27 and Meniere disease. Our patients represent the first reported cases of Meniere disease associated with HLA-B27. Figure 6 . An increase in fluorescence is seen in the hair cells (solid arrow) and in thespiralganglion cells (dottedarrow) in thereaction betweenpatient 2'sserum and the mousecochlear section (original magnification X20).
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The mechanism of HLA-associated autoimmunity is complex. HLA-B27 antigen plays a role in several nonorgan-specific autoimmune disease states, including ankylosing spondylitis, acute anterior uveitis, and Reiter syndrome. In white populations and most other groups, 90% ofpatients with ankylosing spondylitis carry HLA-B27, as opposed to 8% of the general population." The various mechanisms of an autoimmune response in these patients include T-cell-mediated autoantibodies and natural killer cells.IS Most commonly, HLA molecules that are involved in disease predisposition act by preferential peptide presentation to T cells. However, for each target tissue, the mechanism of the autoimmune reaction isdifferent. Wanget al studied a group of34 patients with HLA-B27-associated ankylosing spondylitis and found that 9 (26%) of them had circulating autoantibodies to the inner ear, which may be nonspecific in nature." Our investigation of 2 patients with HLA-B27-associated Meniere disease also found evidence of the presence of autoantibodies against inner ear structures in the serum of both of patients. This was evidenced by the greater fluorescence reaction of the patients' serum with mouse cochlear sections compared with control samples. The goal of our investigation was twofold: (1) to illustrate a possible association between carriage of the HLA-B27 allele and the presentation ofautoimmune inner ear disease or autoimmune Meniere disease symptomatology in 2 patients and (2) to investigate the immunocytologic features of this association-namely the presence of a circulating autoantibody reaction as demonstrated by the patients' serum reactions with mouse inner ear tissue substrates. Based on our findings, we believe there is a possible role of a humoral immune response in the development of Meniere disease in HLA-B27-carrying individuals.
Our investigation has a few limitations. First, the small sample size obviously prevents a generalization of the data to the entire population. A link between HLA-B27and autoimmune Meniere disease will require a much larger sample. Second, only cochlear sections from mice were used as substrates for immune reaction of the serum. Use of human temporal bones and the inclusion of the vestibular organ would enhance such an investigation.
